We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Glycotope Receives Innovation Award Berlin Brandenburg 2010

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Glycotope GmbH, has won the innovation award 2010 jointly presented by the German states of Berlin and Brandenburg in recognition of the company’s GlycoExpress™ technology platform.

GlycoExpress™ combines a very efficient improvement of the activities and side effects of a broad range of protein biopharmaceuticals with the suitability for a much broader patient population and a very high productivity, the company claims. Currently four therapeutic proteins (3 antibodies) have been produced under GMP two of which are currently tested in clinical trials.

“We are highly delighted”, says Dr. Steffen Goletz, CEO, CSO and Founder of Glycotope GmbH. “After receiving the STEP award 2010, winning another prestigious prize within short time is an important recognition of our scientific and corporate advances we have accomplished over the last years”.

With close to 70 employees just at the Biotech-campus in Berlin-Buch, Glycotope has developed into an outstanding representative of the Biotech region Berlin-Brandenburg.